Role of catalase in oxidative stress‐and age‐associated degenerative diseases

A Nandi, LJ Yan, CK Jana, N Das - Oxidative medicine and …, 2019 - Wiley Online Library
Reactive species produced in the cell during normal cellular metabolism can chemically
react with cellular biomolecules such as nucleic acids, proteins, and lipids, thereby causing …

Tau-targeting therapies for Alzheimer disease: current status and future directions

EE Congdon, C Ji, AM Tetlow, Y Jiang… - Nature Reviews …, 2023 - nature.com
Alzheimer disease (AD) is the most common cause of dementia in older individuals. AD is
characterized pathologically by amyloid-β (Aβ) plaques and tau neurofibrillary tangles in the …

Tau aggregation and its interplay with amyloid-β

RM Nisbet, JC Polanco, LM Ittner, J Götz - Acta neuropathologica, 2015 - Springer
Neurofibrillary tangles and amyloid plaques constitute the hallmark brain lesions of
Alzheimer's disease (AD) patients. Tangles are composed of fibrillar aggregates of the …

Astrocyte dysfunction in Alzheimer disease

C Acosta, HD Anderson… - Journal of neuroscience …, 2017 - Wiley Online Library
Astrocytes are glial cells that are distributed throughout the central nervous system in an
arrangement optimal for chemical and physical interaction with neuronal synapses and …

Effects of in vivo conditions on amyloid aggregation

MC Owen, D Gnutt, M Gao, SKTS Wärmländer… - Chemical Society …, 2019 - pubs.rsc.org
One of the grand challenges of biophysical chemistry is to understand the principles that
govern protein misfolding and aggregation, which is a highly complex process that is …

Oxidative stress induced-neurodegenerative diseases: the need for antioxidants that penetrate the blood brain barrier

Y Gilgun-Sherki, E Melamed, D Offen - Neuropharmacology, 2001 - Elsevier
Oxidative stress (OS) has been implicated in the pathophysiology of many neurological,
particularly neurodegenerative diseases. OS can cause cellular damage and subsequent …

Beta-amyloid neurotoxicity requires fibril formation and is inhibited by congo red.

A Lorenzo, BA Yankner - Proceedings of the National …, 1994 - National Acad Sciences
beta-Amyloid (beta A) is normally produced as a nontoxic soluble peptide. In Alzheimer
disease, beta A aggregates and accumulates in the brain as inert diffuse plaques or …

Cellular actions of beta-amyloid precursor protein and its soluble and fibrillogenic derivatives

MP Mattson - Physiological reviews, 1997 - journals.physiology.org
beta-Amyloid precursor protein (beta-APP), the source of the fibrillogenic amyloid beta-
peptide (A beta) that accumulates in the brain of victims of Alzheimer's disease, is a …

Alzheimer's amyloid β-peptide-associated free radical oxidative stress and neurotoxicity

S Varadarajan, S Yatin, M Aksenova… - Journal of structural …, 2000 - Elsevier
Alzheimer's disease, the major dementing disorder of the elderly that affects over 4 million
Americans, is related to amyloid β-peptide, the principal component of senile plaques in …

Apoptosis is induced by beta-amyloid in cultured central nervous system neurons.

DT Loo, A Copani, CJ Pike… - Proceedings of the …, 1993 - National Acad Sciences
The molecular mechanism responsible for the neurodegeneration in Alzheimer disease is
not known; however, accumulating evidence suggests that beta-amyloid peptide (A beta P) …